Bluestem Biosciences, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Bluestem Biosciences, Inc. - overview
Established
2022
Location
Omaha, NE, US
Primary Industry
Biotechnology
About
Based in Nebraska, US, and founded in 2022 by co-founders Billy Hagstrom, Tyler Autera, and Jared Wenger, Bluestem Biosciences, Inc. , aka Bluestem Biosciences, provides a digital biology platform built to design biology for strategic opportunities in agriculture and infrastructure. In July 2022, Bluestem Biosciences, Inc. raised pre-seed funding led by Zero Infinity Partners, Invest Nebraska Corporation.
The company's platform promotes sustainable biomanufacturing research and focuses on environment-friendly chemical synthesis and commodities using specialized biology designed for anaerobic fermentation settings.
Current Investors
Invest Nebraska, Zero Infinity Partners
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Agricultural Chemicals
Website
www.bluestembiosciences.com
Verticals
Clean Technology
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.